Table 1 Demographic and clinical data of patients with BD
Parameter | Patients with BD (n = 109) |
|---|---|
Age, mean ± SD (range) | 35.3 ± 8 (18–58) years |
Sex, male:female | 98:11 (8.9:1) |
Disease duration, median, minimum, maximum, IQR | 9,1, 38, 8.5 years |
Delay in diagnosis, median, minimum, maximum, IQR | 12, 0.2, 216, 48 months |
BDCAF grades 0/1/2/3 | 50/45/11/3 |
Oral ulcers, n(%) | 103 (94.5) |
Genital ulcers, n(%) | 93 (85.3) |
Skin lesions, n(%) | 43 (39.4) |
Eye (uveitis), n(%) | 76(69.7) |
Duration of eye affection, mean ± SD (range) | 86.7 ± 60.1(2–264) months |
Impaired vision, n(%) | 62(56.9) |
Blindness, n(%) | 12(11) |
Cataract, n(%) | 40(36.7) |
Vascular involvement, n(%) | 55 (50.5) |
DVT, n(%) | 29 (26.6) |
DVT (no. of attacks), n(%) | Once 9 (8.3) or twice 20 (18.3) |
Thrombosis (arterial/venous), n(%) | 52 (47.7) |
Thrombosis (no. of attacks), n(%) | Once 27 (24.8) or twice 25 (22.9) |
Aneurysms, n(%) | 14 (12.8) |
Neurological involvement, n(%) | 19 (17.4) |
Cranial nerve affection, n(%) | 12 (11) |
Ataxia, n(%) | 3 (2.8) |
Coma, n(%) | 1 (0.9) |
Stroke, n(%) | 9 (8.3) |
Arthritis, n(%) | 12 (11) |
AVN, n(%) | 4 (3.7) |
Osteoporosis, n(%) | 7 (6.4) |
Diabetes, n(%) | 8 (7.3) |
Mortality, n(%) | 8 (7.3) |
VDI | 3.5 ± 1.8 (1–10) |